Compugen Ltd.
CGEN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.99 | -6.30 | -0.34 | 0.01 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | -19.17 | -22.15 | -14.65 | -16.26 |
| Quality | ||||
| ROIC | -10.11% | -9.73% | -8.85% | -7.85% |
| Gross Margin | 12.74% | -32.46% | -5.08% | 54.11% |
| Cash Conversion Ratio | – | – | – | 7.45 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.73% | 43.46% | 54.37% | 54.88% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.65 | 0.48 | 1.41 | 2.05 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 134.79 | 172.76 | 124.05 | -228.61 |